<
Planning of Medicine Distribution 12th Five -Year Plan is postponed to November
Release time: 2010-09-25 & nbsp & nbsp & nbsp Source:
    Wanzhuang "Outline of the Development Plan for the National Pharmaceutical Distribution Industry (2011-2015)" for the comments draft has ended the consultation opinion of the industry association and the society,stake sports betting appThe stake online sports bettingfinal adjustment after the opinions of the Ministry of Commerce after the opinions of the Commerce。Guo Fanli, a researcher at the pharmaceutical industry of China Investment Consultant, pointed out,Draft for the solicitation of the "Planning" needs to be further adjusted and the necessary document process,and finally send out in the name of multiple departments,Therefore, the 12th Five -Year Plan for Medicine Distribution is likely to be postponed to November。
    Guo Fanli, a researcher at the pharmaceutical industry of China Investment Consultant, pointed out,"Outline of the Development Plan for the National Pharmaceutical Distribution Industry (2011-2015)" was originally scheduled to be introduced in the third quarter of this year,And because of the draft of the "Planning" in August, and the first phase of solicitation of opinions has been completed,Therefore, the industry generally estimates that the 12th Five -Year Plan for Medicine Circulation can meet people as soon as September,However, the time of the "Plan" has been repeatedly delayed to make the medical circulation enterprise lost。
    Guo Fanli pointed out,Of course,Planning of the 12th Five -Year Plan of Medicine Circulation stake online sports bettingstake online sports bettingis delayed that the private pharmaceutical circulation enterprise is restless,and they are undoubted。Kyushu Tong, a leading enterprise of private pharmaceutical circulation as an example,Although the Kyushu Tongbai hand starts,But at present Kyushu is already a private enterprise that has also been deployed nationwide after the National Medicine Group。09 years,On the ranking of the top 100 companies in China,Kyushu general ranking third。
    Guo Fanli pointed at the same time,But,Even if you have this strength,Kyushu, who is a private enterprise of medical circulation, is still excluded from the mainstream competitive market。According to the data display of the China Investment Consultant Industry Research Center,In the second half of 2009,Beijing has formulated the "Selection of Medical Institutional Pharmaceutical Procurement and Distributor Selection Work Plan","Plan" pointed out that 10 distributors should be selected among more than 200 pharmaceutical circulation companies in Beijing in Beijing to distribute all non stake sports betting appstake online sports betting-profit medical institutions and medical insurance institutions in Beijing。
    Jiang Huayang, a researcher at the pharmaceutical industry of China Investment Consultant, pointed out,However, at the beginning of this year, Beijing announced the list of selected enterprises,Kyushu Tong is not included in it。After that,Many pharmaceutical circulation companies including Kyushu Tong have expressed dissatisfaction,Because you can see from 10 selected lists,Enterprises that can be selected have the "national character" background,Although it was forced to abandon this solution in Beijing,But from it, there are obvious unfair treatment for private enterprises and state -owned enterprises。